sitagliptin sandoz 25 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg
sitagliptin sandoz 50 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg
sitagliptin sandoz 100 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 100 mg
januvia 50 mg
orifarm as - sitagliptinfosfatmonohydrat - tablett, filmdrasjert - 50 mg
sitagliptin/metformin krka 50 mg / 1000 mg
krka, d.d. novo mesto - sitagliptin / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 1000 mg
sitagliptin/metformin krka 50 mg / 850 mg
krka, d.d. novo mesto - sitagliptin / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 850 mg
sitagliptin krka 25 mg
krka, d.d. novo mesto - sitagliptin - tablett, filmdrasjert - 25 mg
sitagliptin krka 50 mg
krka, d.d. novo mesto - sitagliptin - tablett, filmdrasjert - 50 mg
sitagliptin krka 100 mg
krka, d.d. novo mesto - sitagliptin - tablett, filmdrasjert - 100 mg
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. triple kombinasjon terapi) som et tillegg til diett og trening hos pasienter ikke kontrollert på deres maksimal tolerert dose av metformin og en sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.